AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia.
about
MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cellsThe mechanism of release of P-TEFb and HEXIM1 from the 7SK snRNP by viral and cellular activators includes a conformational change in 7SKHIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxiaCBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesisThe little elongation complex regulates small nuclear RNA transcriptionHuman mediator subunit MED26 functions as a docking site for transcription elongation factorsThe little elongation complex functions at initiation and elongation phases of snRNA gene transcriptionCovalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers7SK snRNA: a noncoding RNA that plays a major role in regulating eukaryotic transcriptionP-TEFb goes viralTargeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectivesThe Mediator complex: a central integrator of transcriptionRecent progress toward epigenetic therapies: the example of mixed lineage leukemiaHijacked in cancer: the KMT2 (MLL) family of methyltransferasesGetting up to speed with transcription elongation by RNA polymerase IIChromatin signatures of cancerInhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaLeukemia fusion target AF9 is an intrinsically disordered transcriptional regulator that recruits multiple partners via coupled folding and binding.The AFF4 scaffold binds human P-TEFb adjacent to HIV TatCrystal structure of HIV-1 Tat complexed with human P-TEFb and AFF4AFF4 binding to Tat-P-TEFb indirectly stimulates TAR recognition of super elongation complexes at the HIV promoterThe super elongation complex (SEC) and MLL in development and disease.hLARP7 C-terminal domain contains an xRRM that binds the 3' hairpin of 7SK RNAUnveiling novel interactions of histone chaperone Asf1 linked to TREX-2 factors Sus1 and Thp1.Disorders of Transcriptional Regulation: An Emerging Category of Multiple Malformation SyndromesEpigenetics in Cancer: A Hematological PerspectiveNUCKS1, a novel Tat coactivator, plays a crucial role in HIV-1 replication by increasing Tat-mediated viral transcription on the HIV-1 LTR promoterCracking the control of RNA polymerase II elongation by 7SK snRNP and P-TEFbThe Mediator complex and transcription regulationRegulation of MYC expression and differential JQ1 sensitivity in cancer cellsThe leukemia-associated Mllt10/Af10-Dot1l are Tcf4/β-catenin coactivators essential for intestinal homeostasisSR proteins collaborate with 7SK and promoter-associated nascent RNA to release paused polymeraseThe RNA Pol II elongation factor Ell3 marks enhancers in ES cells and primes future gene activationPromoter-proximal pausing of RNA polymerase II: emerging roles in metazoansDegree of recruitment of DOT1L to MLL-AF9 defines level of H3K79 Di- and tri-methylation on target genes and transformation potential.Importance of a specific amino acid pairing for murine MLL leukemias driven by MLLT1/3 or AFF1/4Classifying leukemia types with chromatin conformation data.Identification of commonly dysregulated genes in colorectal cancer by integrating analysis of RNA-Seq data and qRT-PCR validation.A permissive chromatin state regulated by ZFP281-AFF3 in controlling the imprinted Meg3 polycistronTEG-1 CD2BP2 controls miRNA levels by regulating miRISC stability in C. elegans and human cells
P2860
Q21134916-9295B9DA-025E-4856-AF4A-9B570D979C01Q21136168-6468E918-77D9-480E-9650-C452201DB3C4Q24294721-FB66B9A4-750F-4ED7-857A-5C6B74EC8376Q24297763-A41C25D5-4869-4EC1-821F-E593B4F77735Q24300557-90A0D5F3-EF0C-4CB1-AB2F-8D78BA763ACBQ24310867-3E303BFD-9B41-4ECD-9370-B13F728417C5Q24316411-8D48E857-6133-458A-B990-21D71E375DE4Q24605342-0B21D535-0CB1-4F55-9A69-1CA61C760066Q24634280-1BE96233-F97C-437C-9C96-C2B705B38B99Q26741360-E43A40B9-B028-4040-9BB4-D74746172565Q26744441-9222777A-B551-4364-A8CC-C53A88B40374Q26849595-6490F105-2BA6-4C48-976B-E6CB8FCE4E15Q26863577-8B593294-2CA1-4662-8438-8C17051B8F14Q27006839-73FD0323-D39D-4CF7-8B4D-68A4A6D3CB5AQ27023288-3E1BDE4D-D63A-45CF-BA88-5DA479D1EF56Q27024162-5CE351CA-4F8B-4722-A89D-EBE5558AC1A4Q27674674-62CFCF9C-4C00-4D85-92E3-C3AC74B9F5C8Q27675570-89CEC64B-7C92-4C87-8C22-BB2287C7AA93Q27676733-9372F82F-F0C8-4CFF-9CB2-238330D3A488Q27683254-76ACA9DE-DC7F-4E27-B279-35CAF8F5A001Q27683845-9BF9DA41-8367-4611-B62B-8A7A9A91991AQ27692038-9087461C-8A7D-4904-9D1A-CB4B5EC9BAEBQ27728130-E2A17036-6FAE-498E-BF97-8EB391F040F3Q27937370-C3D20CA8-4E26-485A-A603-3D92B206F415Q28076446-7CAC1F08-402B-45F9-A80B-8BFE3CDCD672Q28077082-B696DA5B-A3C6-4C75-BA68-84B4BC3EAFC0Q28115345-7920B6FE-7986-4F5E-B24E-844EC64A5446Q28276848-D15F15BC-E73D-4B7C-A5E8-355682564455Q28299679-2B5363AC-3592-48D6-A9EB-D8F504FE259CQ28306655-B38FB50F-A45B-4760-B730-68243276CE83Q28476157-1189AA41-3330-495A-BCC0-967596535ECBQ28512917-C557D549-B67A-41B8-9B90-16B18FAB3FD1Q28593995-8A3D577C-F966-4F76-88F6-79C9735773FBQ29394946-9FCE024D-BB28-49FB-954C-8EEAD1B702E3Q30300029-6FDE0BF4-0BA2-4F18-9E52-2D8F63D2A10FQ30303155-C3F1D437-CA92-4D96-962C-451F93B7B639Q30835184-2D144AE1-99D3-4F7F-B295-7873B4C3A992Q30938855-43061993-F049-42A0-BABE-42602F2EFC0BQ33554080-74D47332-499C-4BBC-9912-100B3E0CAE21Q33554213-1347CF91-8A81-4B82-9835-29E8B926CE8B
P2860
AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
AFF4, a component of the ELL/P ...... iption elongation to leukemia.
@ast
AFF4, a component of the ELL/P ...... iption elongation to leukemia.
@en
type
label
AFF4, a component of the ELL/P ...... iption elongation to leukemia.
@ast
AFF4, a component of the ELL/P ...... iption elongation to leukemia.
@en
prefLabel
AFF4, a component of the ELL/P ...... iption elongation to leukemia.
@ast
AFF4, a component of the ELL/P ...... iption elongation to leukemia.
@en
P2093
P2860
P50
P1433
P1476
AFF4, a component of the ELL/P ...... iption elongation to leukemia.
@en
P2093
Ali Shilatifard
Chengqi Lin
Edwin R Smith
Hidehisa Takahashi
Ka Chun Lai
Ronald C Conaway
Skylar Martin-Brown
P2860
P304
P356
10.1016/J.MOLCEL.2010.01.026
P577
2010-02-01T00:00:00Z